News

As at October 20, 2017

SaskWorks Diversified (Class A - Series A) $18.1691 SaskWorks Resources (Class R - Series A) $11.2604

SaskWorks Diversified (Class A - Series F) $18.9063 SaskWorks Resources (Class R - Series F) $11.6013

CanniMed Therapeutics Inc. Adds to Executive Leadership Team

CanniMed Therapeutics Inc. (TSX: CMED) (“CanniMed” or the “Company”) is pleased to announce that Howard Harkness and Allan Fowler have joined the Company’s executive leadership team. Mr. Harkness has been appointed Vice President of Marketing and Sales, and Mr. Fowler has joined as Vice President of Business Development and Investor Relations…

Read More

CanniMed Therapeutics Inc. Reports Financial Results for Q3 2017

SASKATOON, Saskatchewan–(BUSINESS WIRE)– CanniMed Therapeutics Inc. (TSX:CMED) (“CanniMed” or the “Company”) today released its financial results for the three and nine months ended July 31, 2017. Highlights Sales of $4.8 million in the quarter were 80 per cent higher than in the comparable period of the prior year and were 29 per cent higher than the second quarter of 2017. Year-to-date sales…

Read More

1 2 3 36

Welcome

Please choose one of the following options to enter the site.

Search FAQs Advisor FAQs Legal Contact Facebook Logout

READ OUR PROSPECTUS > This offering is made only by prospectus. The prospectus contains important detailed information about the securities being offered. Copies of the prospectus may be obtained free of charge from your Investment Advisor or the agent, Industrial Alliance Securities Inc. (www.iavaleursmobilieres.ca). Investors should read the prospectus and consult an Investment Advisor before making an investment decision.